Joanna Szumska1, Maria Qatato1, Maren Rehders1, Dagmar Führer2, Heike Biebermann3, David K Grandy4, Josef Köhrle5, Klaudia Brix1. 1. Department of Life Sciences and Chemistry, Jacobs University Bremen, Bremen, Germany. 2. Department of Endocrinology and Metabolism and Division of Laboratory Research, University of Duisburg-Essen, Essen, Germany. 3. Institut für Experimentelle Pädiatrische Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, Germany. 4. Department of Physiology and Pharmacology, School of Medicine and the Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oreg., USA. 5. Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Abstract
BACKGROUND: The trace amine-associated receptor 1 (Taar1) is one member of the Taar family of G-protein-coupled receptors (GPCR) accepting various biogenic amines as ligands. It has been proposed that Taar1 mediates rapid, membrane-initiated effects of thyronamines, the endogenous decarboxylated and deiodinated relatives of the classical thyroid hormones T4 and T3. OBJECTIVES: Although the physiological actions of thyronamines in general and 3-iodothyronamine (T1AM) in particular are incompletely understood, studies published to date suggest that synthetic T1AM-activated Taar1 signaling antagonizes thyromimetic effects exerted by T3. However, the location of Taar1 is currently unknown. METHODS: To fill this gap in our knowledge we employed immunofluorescence microscopy and a polyclonal antibody to detect Taar1 protein expression in thyroid tissue from Fisher rats, wild-type and taar1-deficient mice, and in the polarized FRT cells. RESULTS: With this approach we found that Taar1 is expressed in the membranes of subcellular compartments of the secretory pathway and on the apical plasma membrane of FRT cells. Three-dimensional analyses further revealed Taar1 immunoreactivity in cilial extensions of postconfluent FRT cell cultures that had formed follicle-like structures. CONCLUSIONS: The results suggest Taar1 transport along the secretory pathway and its accumulation in the primary cilium of thyrocytes. These findings are of significance considering the increasing interest in the role of cilia in harboring functional GPCR. We hypothesize that thyronamines can reach and activate Taar1 in thyroid follicular epithelia by acting from within the thyroid follicle lumen, their potential site of synthesis, as part of a nonclassical mechanism of thyroid autoregulation.
BACKGROUND: The trace amine-associated receptor 1 (Taar1) is one member of the Taar family of G-protein-coupled receptors (GPCR) accepting various biogenic amines as ligands. It has been proposed that Taar1 mediates rapid, membrane-initiated effects of thyronamines, the endogenous decarboxylated and deiodinated relatives of the classical thyroid hormones T4 and T3. OBJECTIVES: Although the physiological actions of thyronamines in general and 3-iodothyronamine (T1AM) in particular are incompletely understood, studies published to date suggest that synthetic T1AM-activated Taar1 signaling antagonizes thyromimetic effects exerted by T3. However, the location of Taar1 is currently unknown. METHODS: To fill this gap in our knowledge we employed immunofluorescence microscopy and a polyclonal antibody to detect Taar1 protein expression in thyroid tissue from Fisher rats, wild-type and taar1-deficient mice, and in the polarized FRT cells. RESULTS: With this approach we found that Taar1 is expressed in the membranes of subcellular compartments of the secretory pathway and on the apical plasma membrane of FRT cells. Three-dimensional analyses further revealed Taar1 immunoreactivity in cilial extensions of postconfluent FRT cell cultures that had formed follicle-like structures. CONCLUSIONS: The results suggest Taar1 transport along the secretory pathway and its accumulation in the primary cilium of thyrocytes. These findings are of significance considering the increasing interest in the role of cilia in harboring functional GPCR. We hypothesize that thyronamines can reach and activate Taar1 in thyroid follicular epithelia by acting from within the thyroid follicle lumen, their potential site of synthesis, as part of a nonclassical mechanism of thyroid autoregulation.
Authors: Carolin S Hoefig; Kostja Renko; Susanne Piehl; Thomas S Scanlan; Mariarita Bertoldi; Thomas Opladen; Georg Friedrich Hoffmann; Jeannette Klein; Oliver Blankenstein; Ulrich Schweizer; Josef Köhrle Journal: Mol Cell Endocrinol Date: 2011-10-28 Impact factor: 4.102
Authors: J R Bunzow; M S Sonders; S Arttamangkul; L M Harrison; G Zhang; D I Quigley; T Darland; K L Suchland; S Pasumamula; J L Kennedy; S B Olson; R E Magenis; S G Amara; D K Grandy Journal: Mol Pharmacol Date: 2001-12 Impact factor: 4.436
Authors: Bianca Friedrichs; Carmen Tepel; Thomas Reinheckel; Jan Deussing; Kurt von Figura; Volker Herzog; Christoph Peters; Paul Saftig; Klaudia Brix Journal: J Clin Invest Date: 2003-06 Impact factor: 14.808
Authors: Nicolas F Berbari; Andrew D Johnson; Jacqueline S Lewis; Candice C Askwith; Kirk Mykytyn Journal: Mol Biol Cell Date: 2008-02-06 Impact factor: 4.138
Authors: I S Zhukov; L G Kubarskaya; I Y Tissen; A A Kozlova; S G Dagayev; V A Kashuro; O L Vlasova; E L Sinitca; I V Karpova; R R Gainetdinov Journal: Cell Mol Neurobiol Date: 2019-08-09 Impact factor: 5.046
Authors: Ilya S Zhukov; Maria A Ptukha; Ekaterina A Zolotoverkhaja; Ekaterina L Sinitca; Ilya Y Tissen; Inessa V Karpova; Anna B Volnova; Raul R Gainetdinov Journal: Brain Sci Date: 2022-05-08
Authors: Xiaoqun Zhang; Ioannis Mantas; Alexandra Alvarsson; Takashi Yoshitake; Mohammadreza Shariatgorji; Marcela Pereira; Anna Nilsson; Jan Kehr; Per E Andrén; Mark J Millan; Karima Chergui; Per Svenningsson Journal: Front Pharmacol Date: 2018-03-01 Impact factor: 5.810